Skip to main content

Table 3 Evaluating the association between Brachial FMD and demographic, clinical and laboratory risk factors by logistic regression

From: Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes

Model

B

S.E.

P-value

OR (95% CI)

Gender, n (%)

 

0.438

0.024

0.371 (0.157–0.875)

Women

-0.991

   

Men

Ref.

   

Hypertension, n (%)

 

0.439

0.010

3.114 (1.318–7.356)

Yes

1.136

   

No

Ref.

   

Statin Medication, n (%)

 

0.439

0.069

2.226 (0.941–5.267)

Yes

0.800

   

No

Ref.

   

GFR, (mL/min/1.73m2)

-0.027

0.015

0.077

0.973 (0.944–1.003)

NAFLD Status, n (%)

 

0.397

0.017

2.581 (1.185–5.624)

NAFLD

0.948

   

Non-NAFLD

Ref.

   
  1. Dependent: abnormal FMD defined as (FMD ≤ 7%)
  2. Independents: Age; Sex; Smoking; Diabetes duration; BMI; SBP; DBP; HTN; DLP; Statin medication; Insulin medication; FBS; HbA1C; GFR; TG; Chol; HDL; LDL; AST; ALT; LSM; NAFLD
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us